Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02952248
Title A Trial to Find and Investigate a Safe Dose of a New Substance (BI 754091) for Patients With Solid Tumours
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Boehringer Ingelheim

urinary bladder cancer

triple-receptor negative breast cancer

ovarian cancer

Advanced Solid Tumor

stomach cancer

renal cell carcinoma

lung non-small cell carcinoma




Age Groups: senior | adult
Covered Countries USA | CAN

No variant requirements are available.